NVCR FY 2023 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

FY 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$509M-5.3% YoY

Gross Profit

$381M74.8% margin

Operating Income

-$233M-45.7% margin

Net Income

-$207M-40.6% margin

EPS (Diluted)

$-1.95

Cash Flow

Operating Cash Flow

-$73M

Free Cash Flow

-$100M

Stock-Based Comp.

$116M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$784M

Stockholders' Equity

$362M

Cash & Equivalents

$241M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$509M	$538M	-5.3%
Gross Profit	$381M	$423M	-9.9%
Operating Income	-$233M	-$90M	-160.1%
Net Income	-$207M	-$93M	-123.7%